CandlesenseCandlesense
BMY•benzinga•

Bristol Myers Squibb Forecasts 2024 Adjusted EPS Of $0.75-$0.95 Versus Prior Guidance Of $0.60-$0.90 And Consensus Of $0.71

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on October 31, 2024 by benzinga

← Back to BMY News
    Bristol Myers Squibb Forecasts 2024 Adjusted EPS Of $0.75-$0.95 Versus Prior Guidance Of $0.60-$0.90 And Consensus Of $0.71 | BMY Stock News | Candlesense